McCormick & Company stock faces analyst cuts and Unilever deal talks ahead of Q1 earnings

JPMorgan slashes McCormick & Company (NYSE:MKC, ISIN: US5797802064) price target to $67 from $78 amid Unilever Foods acquisition rumors and upcoming Q1 results on March 31. Shares lag peers despite undervaluation signals and Flavor of the Year buzz.

McCormick & Company stock has come under fresh pressure as JPMorgan Chase cut its price target to $67 from $78 while maintaining an Overweight rating. The adjustment coincides with reports of the company mulling an acquisition of Unilever's Foods business in an all-stock deal that could materialize within weeks. Investors eye these developments ahead of fiscal 2026 Q1 earnings on March 31, where analysts project diluted EPS of $0.61.

As of: 25.03.2026

By Elena Voss, Consumer Staples Analyst: McCormick's blend of flavor innovation and potential M&A reshape positions it for recovery in a value-conscious staples sector.

Analyst Downgrades Signal Caution on Valuation

JPMorgan analyst Thomas Palmer lowered the target on McCormick & Company (NYSE:MKC) to $67, reflecting broader analyst caution after recent ratings adjustments. This follows UBS cutting its target to $59 from $67 on March 20 and other firms trimming estimates earlier in the year. The consensus average target now stands at $71.87, implying about 40% upside from recent levels around $51-$52 on NYSE in USD.

These moves highlight concerns over near-term growth in a high-interest-rate environment squeezing consumer spending on premium flavors. McCormick, a leader in herbs, spices, and seasonings, relies on pricing power and volume growth, both under scrutiny. Yet JPMorgan retains Overweight, suggesting belief in long-term flavor demand.

US investors should note the stock's 23.5% year-to-date decline on NYSE in USD, starkly underperforming the S&P 500's gains. This divergence creates a potential entry if earnings deliver beats, as McCormick has mixed history but strong brand moats.

Unilever Foods Acquisition Rumors Stir Portfolio Rethink

Reports indicate McCormick is considering buying Unilever's Foods business, potentially in an all-stock transaction soon. McCormick reported $6.8 billion in fiscal 2025 sales, and this deal could expand its portfolio in condiments and spreads. Management confirmed discussions, aiming to streamline operations and unlock value.

The market reacted mutedly, with shares dipping 1.5% post-announcement on NYSE in USD. Uncertainty around deal structure, timing, and integration risks tempers enthusiasm. For consumer staples, such M&A often boosts scale but demands flawless execution amid antitrust scrutiny.

This plays into McCormick's strategy of global expansion in high-growth categories like beverages and snacks, particularly Asia-Pacific. US investors benefit from diversified revenue, as domestic staples face pricing fatigue.

Flavor of the Year Campaign Builds Momentum

McCormick named Black Currant its 2026 Flavor of the Year, launching seasoning and sugar products alongside a New York Sensoria experience. This marketing push targets health-oriented consumers, pairing with partnerships in snacks and beverages.

Despite buzz, shares show weak momentum: 30-day return of 23.93% negative and 1-year total return of 33.35% negative. Valuation models peg fair value at $73.31, suggesting 28.9% undervaluation versus $52.11 close on NYSE in USD.

Innovation remains key for staples firms. McCormick's $7 billion annual sales across 150 countries leverage brands like Lawry's and Zatarain's. US investors should watch if flavor trends drive volume recovery post-earnings.

Q1 Earnings Preview: Expectations and Track Record

Fiscal 2026 Q1 results arrive March 31 pre-market, with consensus EPS at $0.61, up 1.7% year-over-year. Full-year 2026 EPS seen at $3.09, rising to $3.36 in 2027. McCormick beat EPS in two of last four quarters.

Focus areas include sales volumes, pricing, and margin stability. Consumer segment faces soft demand, while Flavor Solutions benefits from foodservice recovery. Market cap around $14.3 billion underscores scale.

Compared to XLP ETF up 4.4% YTD, MKC down 23.5% signals undervaluation or execution worries. Moderate Buy consensus from 13 analysts, with $75.92 mean target.

Why US Investors Should Watch McCormick Now

McCormick serves US retail, manufacturers, and foodservice with steady demand for flavor enhancement. Amid inflation, its pricing power differentiates from peers. Potential Unilever deal adds bolt-on growth without heavy debt.

GF Value estimates $89.35, implying 74% upside from $51.42 on NYSE in USD. Outperform consensus (2.4 rating) from 15 firms supports allocation. For dividend-focused US portfolios, McCormick offers stability in staples.

Global reach mitigates US slowdowns, with Asia-Pacific expansion key. Earnings clarity could catalyze re-rating versus lagging peers.

Risks and Open Questions Ahead

Deal uncertainty looms: antitrust hurdles, dilution from stock swap, integration costs. Weak consumer traffic pressures volumes, margins vulnerable to commodity costs.

Analyst cuts reflect macro headwinds; failure to beat EPS risks further downside. 52-week underperformance at 35.1% negative amplifies volatility.

US investors face sector rotation risks if rates stay high. Watch guidance for 2026 growth confirmation. Moderate Buy hides split views: 7 Strong Buys, 4 Holds, 1 Strong Sell.

McCormick's path hinges on execution: flavor wins, deal closure, earnings beats. Staples resilience favors patient holders.

Disclaimer: This is not investment advice. Stocks are volatile financial instruments.